Gene therapy shows promise against hemophilia
Ten men with severe hemophilia received a virus based gene therapy restoring clotting factor production. The early results show bleeding episodes drop from about one per month to less than one per year with no serious side effects. Follow up averages one year, with potential long term benefits and cost considerations noted.
MENTIONED IN THIS ARTICLE
New England Journal of Medicine
Bill Konduras
Porteus
BioMarin Pharmaceutical
American Society of Hematology
Sangamo Therapeutics
Pfizer launches its own generic Viagra in race to cut prices
Pfizer will begin selling a cheaper generic Viagra next Monday as first generics enter the market. Teva may price later generic versions, while Pfizer also rolls out discount programs including Pfizer Direct to offer brand Viagra at reduced copays and online home delivery.
MENTIONED IN THIS ARTICLE
Trenton
N.J
Pfizer
Pfizer Inc
Teva Pharmaceuticals
Nachum Katlowitz
New York
Staten Island University Hospital
Eli Lilly
U.S
Pfizer Direct
Breast cancer risk linked to some hormonal contraceptives study says
A Danish study finds lower estrogen pills and progestin only devices modestly raise breast cancer risk with long use. Net risk is small about one extra case per 7 700 women annually. Experts urge weighing benefits against cancer risks and considering non hormonal options for some women.
MENTIONED IN THIS ARTICLE
Chicago
JoAnn Manson
Harvard
Brigham and Women’s Hospital
Manson
Mia Gaudet
American Cancer Society
Gaudet
United States
Denmark
New England Journal of Medicine
Novo Nordisk Foundation
Novo Nordisk
Also Mentioned on This Page
Marilynn Marchion
The
Associated Press
Lindsey George
Children’s Hospital of
Philadelphia
Spark Therapeutics
Spark
Matthew Porteus
Stanford University
Jay
Bill Konduros
Toronto
Jay Konduros
Iyc
Bill
Cambridge
Ontario
Dst
Sieeernie Mattresses
S. Main ST
Wellington
2.Com
Isi